11/27/24 16:06  | 11/25/24  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 8 | 126 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/12/24 18:10  | 8/25/24  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 8 | 117 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/29/24 19:12  | 5/25/24  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 9 | 108 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/27/24 19:56  | 2/25/24  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 10 | 99 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/28/23 19:01  | 11/25/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 11 | 90 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/29/23 18:49  | 8/25/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 12 | 81 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/26/23 19:30  | 5/25/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 14 | 72 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/23 18:25  | 2/25/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 17 | 63 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/22 17:21  | 11/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 20 | 54 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/29/22 21:16  | 8/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/22 21:11  | 2/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 9 | 50 | 27 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/21 19:51  | 11/25/21  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | CA | D |  | M.d | 0 | 0.00 | 0 | 18 | New | 18 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/11/18 16:49  | 9/7/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S | -16 | 9.00 | 0 | -2 | -1 | 214 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/6/18 17:08  | 9/5/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.m | -114 | 9.10 | 0 | -13 | -5 | 216 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/23/18 16:33  | 7/20/18  | RUBY | Rubius Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pomerantz Roger | MA | D |  | P | 2 | 23.00 | 0 | 0 | New | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/12/18 17:15  | 7/11/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 1 | 0.7100 | 0 | 1 | 0 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/12/18 17:15  | 7/11/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -9 | 9.01 | 0 | -1 | 0 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/10/18 17:49  | 7/6/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 23 | 0.7100 | 0 | 32 | 17 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/10/18 17:49  | 7/6/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -295 | 9.12 | 0 | -32 | -12 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/29/18 17:12  | 6/28/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 19 | 0.7100 | 0 | 26 | 13 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/29/18 17:12  | 6/28/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -238 | 9.15 | 0 | -26 | -10 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/27/18 21:06  | 6/25/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 39 | 0.7100 | 0 | 55 | 31 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/27/18 21:06  | 6/25/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -595 | 9.16 | 0 | -65 | -22 | 228 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/22/18 21:11  | 6/20/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.m | -794 | 9.28 | 0 | -86 | -26 | 239 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/10/18 16:44  | 5/9/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S | -2 | 9.00 | 0 | 0 | 0 | 324 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/25/18 16:39  | 1/24/18  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 29 | 0.7100 | 0 | 40 | 14 | 325 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/26/17 16:48  | 7/25/17  | CFRX | Contrafect Corp | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | PA | D |  | P.d | 1 | 1.24 | 0 | 1 | New | 1 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/20/17 16:36  | 7/18/17  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 71 | 0.7100 | 0 | 101 | 55 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/28/16 18:01  | 7/27/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 14 | 0.7100 | 9 | 20 | 12 | 184 | D |  | -4 | 41 | 17 | 16 | 17 | 5 | 2 | -69 | -75 | -72 | -67 | -74 |  | 
7/28/16 18:01  | 7/27/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -700 | 35.00 | 9 | -20 | -10 | 184 | D |  | -4 | 41 | 17 | 16 | 17 | 5 | 2 | -69 | -75 | -72 | -67 | -74 |  | 
7/7/16 17:27  | 7/5/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 63 | 0.7100 | 11 | 88 | 92 | 184 | D |  | -25 | -13 | 1 | 0 | -1 | 6 | 3 | 0 | 6 | -69 | -61 | -63 |  | 
7/7/16 17:27  | 7/5/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -2,597 | 29.45 | 11 | -88 | -32 | 184 | D |  | -25 | -13 | 1 | 0 | -1 | 6 | 3 | 0 | 6 | -69 | -61 | -63 |  | 
7/5/16 17:30  | 7/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 40 | 0.7100 | 11 | 57 | 45 | 184 | D |  | -25 | -15 | 6 | 4 | -13 | 2 | 2 | 3 | 5 | -65 | -56 | -64 |  | 
7/5/16 17:30  | 7/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -1,693 | 29.81 | 11 | -57 | -24 | 184 | D |  | -25 | -15 | 6 | 4 | -13 | 2 | 2 | 3 | 5 | -65 | -56 | -64 |  | 
6/6/16 16:30  | 6/2/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 53 | 0.7100 | 7 | 74 | 68 | 184 | D |  |  | -13 | 8 | -6 | 25 | 0 | -2 | 2 | 5 | -10 | -73 | -74 |  | 
6/6/16 16:30  | 6/2/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -2,408 | 32.52 | 7 | -74 | -29 | 184 | D |  |  | -13 | 8 | -6 | 25 | 0 | -2 | 2 | 5 | -10 | -73 | -74 |  | 
6/2/16 21:37  | 6/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 50 | 0.7100 | 7 | 71 | 63 | 184 | D |  |  | -14 | 16 | 1 | 22 | 7 | 6 | -7 | 7 | -10 | -69 | -71 |  | 
6/2/16 21:37  | 6/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -2,165 | 30.51 | 7 | -71 | -28 | 184 | D |  |  | -14 | 16 | 1 | 22 | 7 | 6 | -7 | 7 | -10 | -69 | -71 |  | 
5/25/16 21:11  | 5/24/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 7 | 0.7100 | 6 | 10 | 6 | 184 | D |  |  | -10 | 22 | -1 | 13 | 26 | 9 | 1 | 6 | 5 | -58 | -58 |  | 
5/25/16 21:11  | 5/24/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -294 | 30.00 | 6 | -10 | -5 | 184 | D |  |  | -10 | 22 | -1 | 13 | 26 | 9 | 1 | 6 | 5 | -58 | -58 |  | 
5/19/16 16:41  | 5/18/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 114 | 0.7100 | 5 | 161 | 708 | 184 | D |  |  | -7 | 11 | -14 | -8 | 5 | 14 | 5 | 5 | 7 | -59 | -56 |  | 
5/9/16 21:31  | 5/6/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 6 | 0.7100 | 5 | 9 | 60 | 23 | D |  |  | -29 | -4 | -2 | -20 | -20 | -13 | 1 | -8 | 29 | -67 | -65 |  | 
5/9/16 21:31  | 5/6/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -207 | 24.31 | 5 | -9 | -27 | 23 | D |  |  | -29 | -4 | -2 | -20 | -20 | -13 | 1 | -8 | 29 | -67 | -65 |  | 
5/6/16 16:28  | 5/4/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 42 | 0.7100 | 5 | 59 |  | 23 | D |  |  | -20 | -5 | 2 | -16 | -20 | -15 | 7 | -3 | 32 | -59 | -54 |  | 
5/6/16 16:28  | 5/4/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -1,550 | 26.13 | 5 | -59 | -72 | 23 | D |  |  | -20 | -5 | 2 | -16 | -20 | -15 | 7 | -3 | 32 | -59 | -54 |  | 
5/4/16 17:06  | 5/2/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 48 | 0.7100 | 6 | 67 |  | 23 | D |  |  | -6 | 8 | 11 | -8 | -13 | -6 | -5 | -1 | 20 | -61 | -57 |  | 
5/4/16 17:06  | 5/2/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -1,933 | 28.70 | 6 | -67 | -75 | 23 | D |  |  | -6 | 8 | 11 | -8 | -13 | -6 | -5 | -1 | 20 | -61 | -57 |  | 
4/11/16 17:47  | 4/7/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.d | 6 | 0.6673 | 8 | 9 | 68 | 23 | D |  |  | 6 | 1 | 25 | 25 | 23 | 11 | 1 | -1 | -14 | -1 | -61 | -63 | 
4/11/16 17:47  | 4/7/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.d | -276 | 30.00 | 8 | -9 | -29 | 23 | D |  |  | 6 | 1 | 25 | 25 | 23 | 11 | 1 | -1 | -14 | -1 | -61 | -63 | 
4/5/16 20:59  | 4/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | M.dm | 65 | 0.4800 | 7 | 136 |  | 23 | D |  |  | 10 | -19 | 18 | 9 | 15 | 13 | 7 | 8 | -1 | 7 | -55 | -59 | 
4/5/16 20:59  | 4/1/16  | MCRB | Seres Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pomerantz Roger | MA | DO | P,CEO | S.dm | -3,694 | 27.20 | 7 | -136 | -86 | 23 | D |  |  | 10 | -19 | 18 | 9 | 15 | 13 | 7 | 8 | -1 | 7 | -55 | -59 |